Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1940272 AUSTIN, TX
Back to KPTI Full portfolio

Position in KPTI

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$761,619
+$393,619 QoQ
Shares Held
136,736
+173.5% QoQ
Ownership
0.603%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Derivatives in KPTI

reported options exposure · as of Mar 31, 2026
CallValue
$1,142,964
CallShares
205,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7 CRNX
Crinetics Pharmaceuticals, Inc.
 1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in KPTI

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,142,964 205,200
2026-03-31 $761,619 136,736
2025-12-31 $368,000 50,000
2025-09-30 $163,500 25,000
2024-12-31 $13,520 20,000
2024-03-31 $2,233 1,479